Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2

Briony Shaw, Jake Shortt, Michael Low, Benjamin Rogers, Zane Kaplan, Pasquale Fedele, Gareth Gregory, Shahla Vilcassim, Michael Gilbertson, George Grigoriadis, Stephen Opat

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.

Original languageEnglish
Pages (from-to)2172-2175
Number of pages4
JournalInternal Medicine Journal
Issue number12
Publication statusPublished - Dec 2022


  • cancer
  • COVID-19
  • haematological malignancy
  • haematological neoplasm
  • vaccination

Cite this